Global Circulating Biomarker for Liquid Biopsy Market Growth (Status and Outlook) 2022-2028

January 2022 | 86 pages | ID: G9C1EFE1F388EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Circulating Biomarker for Liquid Biopsy will have significant change from previous year. According to our (LP Information) latest study, the global Circulating Biomarker for Liquid Biopsy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Circulating Biomarker for Liquid Biopsy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Circulating Biomarker for Liquid Biopsy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Circulating Biomarker for Liquid Biopsy market, reaching US$ million by the year 2028. As for the Europe Circulating Biomarker for Liquid Biopsy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Circulating Biomarker for Liquid Biopsy players cover Abbott Laboratories, Becton, Dickinson and Company, GE Healthcare, and Epigenomics AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Circulating Biomarker for Liquid Biopsy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

• Circulating Tumor Cells (CTCs)
• Circulating Tumor DNA (ctDNA)
• Cell-Free DNA (cfDNA)
• Extracellular Vesicles (EVs)
• Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

• Early Cancer Screening
• Therapy Selection
• Treatment Monitoring
• Recurrence Monitoring Orthopedics

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

• Abbott Laboratories
• Becton, Dickinson and Company
• GE Healthcare
• Epigenomics AG
• Agilent Technologies
• Biocept
• Affymetrix
• Fluxion Biosciences

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Circulating Biomarker for Liquid Biopsy Market Size 2017-2028
  2.1.2 Circulating Biomarker for Liquid Biopsy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Circulating Biomarker for Liquid Biopsy Segment by Type
  2.2.1 Circulating Tumor Cells (CTCs)
  2.2.2 Circulating Tumor DNA (ctDNA)
  2.2.3 Cell-Free DNA (cfDNA)
  2.2.4 Extracellular Vesicles (EVs)
  2.2.5 Others
2.3 Circulating Biomarker for Liquid Biopsy Market Size by Type
  2.3.1 Circulating Biomarker for Liquid Biopsy Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Circulating Biomarker for Liquid Biopsy Market Size Market Share by Type (2017-2022)
2.4 Circulating Biomarker for Liquid Biopsy Segment by Application
  2.4.1 Early Cancer Screening
  2.4.2 Therapy Selection
  2.4.3 Treatment Monitoring
  2.4.4 Recurrence Monitoring Orthopedics
2.5 Circulating Biomarker for Liquid Biopsy Market Size by Application
  2.5.1 Circulating Biomarker for Liquid Biopsy Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application (2017-2022)

3 CIRCULATING BIOMARKER FOR LIQUID BIOPSY MARKET SIZE BY PLAYER

3.1 Circulating Biomarker for Liquid Biopsy Market Size Market Share by Players
  3.1.1 Global Circulating Biomarker for Liquid Biopsy Revenue by Players (2020-2022)
  3.1.2 Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Players (2020-2022)
3.2 Global Circulating Biomarker for Liquid Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CIRCULATING BIOMARKER FOR LIQUID BIOPSY BY REGIONS

4.1 Circulating Biomarker for Liquid Biopsy Market Size by Regions (2017-2022)
4.2 Americas Circulating Biomarker for Liquid Biopsy Market Size Growth (2017-2022)
4.3 APAC Circulating Biomarker for Liquid Biopsy Market Size Growth (2017-2022)
4.4 Europe Circulating Biomarker for Liquid Biopsy Market Size Growth (2017-2022)
4.5 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022)
5.2 Americas Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022)
5.3 Americas Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Circulating Biomarker for Liquid Biopsy Market Size by Region (2017-2022)
6.2 APAC Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022)
6.3 APAC Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Circulating Biomarker for Liquid Biopsy by Country (2017-2022)
7.2 Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022)
7.3 Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Circulating Biomarker for Liquid Biopsy by Region (2017-2022)
8.2 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022)
8.3 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CIRCULATING BIOMARKER FOR LIQUID BIOPSY MARKET FORECAST

10.1 Global Circulating Biomarker for Liquid Biopsy Forecast by Regions (2023-2028)
  10.1.1 Global Circulating Biomarker for Liquid Biopsy Forecast by Regions (2023-2028)
  10.1.2 Americas Circulating Biomarker for Liquid Biopsy Forecast
  10.1.3 APAC Circulating Biomarker for Liquid Biopsy Forecast
  10.1.4 Europe Circulating Biomarker for Liquid Biopsy Forecast
  10.1.5 Middle East & Africa Circulating Biomarker for Liquid Biopsy Forecast
10.2 Americas Circulating Biomarker for Liquid Biopsy Forecast by Country (2023-2028)
  10.2.1 United States Circulating Biomarker for Liquid Biopsy Market Forecast
  10.2.2 Canada Circulating Biomarker for Liquid Biopsy Market Forecast
  10.2.3 Mexico Circulating Biomarker for Liquid Biopsy Market Forecast
  10.2.4 Brazil Circulating Biomarker for Liquid Biopsy Market Forecast
10.3 APAC Circulating Biomarker for Liquid Biopsy Forecast by Region (2023-2028)
  10.3.1 China Circulating Biomarker for Liquid Biopsy Market Forecast
  10.3.2 Japan Circulating Biomarker for Liquid Biopsy Market Forecast
  10.3.3 Korea Circulating Biomarker for Liquid Biopsy Market Forecast
  10.3.4 Southeast Asia Circulating Biomarker for Liquid Biopsy Market Forecast
  10.3.5 India Circulating Biomarker for Liquid Biopsy Market Forecast
  10.3.6 Australia Circulating Biomarker for Liquid Biopsy Market Forecast
10.4 Europe Circulating Biomarker for Liquid Biopsy Forecast by Country (2023-2028)
  10.4.1 Germany Circulating Biomarker for Liquid Biopsy Market Forecast
  10.4.2 France Circulating Biomarker for Liquid Biopsy Market Forecast
  10.4.3 UK Circulating Biomarker for Liquid Biopsy Market Forecast
  10.4.4 Italy Circulating Biomarker for Liquid Biopsy Market Forecast
  10.4.5 Russia Circulating Biomarker for Liquid Biopsy Market Forecast
10.5 Middle East & Africa Circulating Biomarker for Liquid Biopsy Forecast by Region (2023-2028)
  10.5.1 Egypt Circulating Biomarker for Liquid Biopsy Market Forecast
  10.5.2 South Africa Circulating Biomarker for Liquid Biopsy Market Forecast
  10.5.3 Israel Circulating Biomarker for Liquid Biopsy Market Forecast
  10.5.4 Turkey Circulating Biomarker for Liquid Biopsy Market Forecast
  10.5.5 GCC Countries Circulating Biomarker for Liquid Biopsy Market Forecast
10.6 Global Circulating Biomarker for Liquid Biopsy Forecast by Type (2023-2028)
10.7 Global Circulating Biomarker for Liquid Biopsy Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 Abbott Laboratories
  11.1.1 Abbott Laboratories Company Information
  11.1.2 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Product Offered
  11.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 Abbott Laboratories Main Business Overview
  11.1.5 Abbott Laboratories Latest Developments
11.2 Becton, Dickinson and Company
  11.2.1 Becton, Dickinson and Company Company Information
  11.2.2 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Product Offered
  11.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 Becton, Dickinson and Company Main Business Overview
  11.2.5 Becton, Dickinson and Company Latest Developments
11.3 GE Healthcare
  11.3.1 GE Healthcare Company Information
  11.3.2 GE Healthcare Circulating Biomarker for Liquid Biopsy Product Offered
  11.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 GE Healthcare Main Business Overview
  11.3.5 GE Healthcare Latest Developments
11.4 Epigenomics AG
  11.4.1 Epigenomics AG Company Information
  11.4.2 Epigenomics AG Circulating Biomarker for Liquid Biopsy Product Offered
  11.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Revenue, Gross Margin and Market Share (2020-2022)
  11.4.4 Epigenomics AG Main Business Overview
  11.4.5 Epigenomics AG Latest Developments
11.5 Agilent Technologies
  11.5.1 Agilent Technologies Company Information
  11.5.2 Agilent Technologies Circulating Biomarker for Liquid Biopsy Product Offered
  11.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Revenue, Gross Margin and Market Share (2020-2022)
  11.5.4 Agilent Technologies Main Business Overview
  11.5.5 Agilent Technologies Latest Developments
11.6 Biocept
  11.6.1 Biocept Company Information
  11.6.2 Biocept Circulating Biomarker for Liquid Biopsy Product Offered
  11.6.3 Biocept Circulating Biomarker for Liquid Biopsy Revenue, Gross Margin and Market Share (2020-2022)
  11.6.4 Biocept Main Business Overview
  11.6.5 Biocept Latest Developments
11.7 Affymetrix
  11.7.1 Affymetrix Company Information
  11.7.2 Affymetrix Circulating Biomarker for Liquid Biopsy Product Offered
  11.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Revenue, Gross Margin and Market Share (2020-2022)
  11.7.4 Affymetrix Main Business Overview
  11.7.5 Affymetrix Latest Developments
11.8 Fluxion Biosciences
  11.8.1 Fluxion Biosciences Company Information
  11.8.2 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Product Offered
  11.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Revenue, Gross Margin and Market Share (2020-2022)
  11.8.4 Fluxion Biosciences Main Business Overview
  11.8.5 Fluxion Biosciences Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Circulating Biomarker for Liquid Biopsy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Circulating Tumor Cells (CTCs)
Table 3. Major Players of Circulating Tumor DNA (ctDNA)
Table 4. Major Players of Cell-Free DNA (cfDNA)
Table 5. Major Players of Extracellular Vesicles (EVs)
Table 6. Major Players of Others
Table 7. Circulating Biomarker for Liquid Biopsy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Circulating Biomarker for Liquid Biopsy Market Size Market Share by Type (2017-2022)
Table 10. Circulating Biomarker for Liquid Biopsy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application (2017-2022)
Table 13. Global Circulating Biomarker for Liquid Biopsy Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Player (2020-2022)
Table 15. Circulating Biomarker for Liquid Biopsy Key Players Head office and Products Offered
Table 16. Circulating Biomarker for Liquid Biopsy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Circulating Biomarker for Liquid Biopsy Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Circulating Biomarker for Liquid Biopsy Market Size Market Share by Regions (2017-2022)
Table 21. Americas Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Circulating Biomarker for Liquid Biopsy Market Size Market Share by Country (2017-2022)
Table 23. Americas Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Circulating Biomarker for Liquid Biopsy Market Size Market Share by Type (2017-2022)
Table 25. Americas Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application (2017-2022)
Table 27. APAC Circulating Biomarker for Liquid Biopsy Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Circulating Biomarker for Liquid Biopsy Market Size Market Share by Region (2017-2022)
Table 29. APAC Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Circulating Biomarker for Liquid Biopsy Market Size Market Share by Type (2017-2022)
Table 31. APAC Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application (2017-2022)
Table 33. Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Circulating Biomarker for Liquid Biopsy Market Size Market Share by Country (2017-2022)
Table 35. Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Circulating Biomarker for Liquid Biopsy Market Size Market Share by Type (2017-2022)
Table 37. Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Circulating Biomarker for Liquid Biopsy
Table 46. Key Market Challenges & Risks of Circulating Biomarker for Liquid Biopsy
Table 47. Key Industry Trends of Circulating Biomarker for Liquid Biopsy
Table 48. Global Circulating Biomarker for Liquid Biopsy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Circulating Biomarker for Liquid Biopsy Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Circulating Biomarker for Liquid Biopsy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Circulating Biomarker for Liquid Biopsy Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Circulating Biomarker for Liquid Biopsy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Circulating Biomarker for Liquid Biopsy Market Size Market Share Forecast by Application (2023-2028)
Table 54. Abbott Laboratories Details, Company Type, Circulating Biomarker for Liquid Biopsy Area Served and Its Competitors
Table 55. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Product Offered
Table 56. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Abbott Laboratories Main Business
Table 58. Abbott Laboratories Latest Developments
Table 59. Becton, Dickinson and Company Details, Company Type, Circulating Biomarker for Liquid Biopsy Area Served and Its Competitors
Table 60. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Product Offered
Table 61. Becton, Dickinson and Company Main Business
Table 62. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Becton, Dickinson and Company Latest Developments
Table 64. GE Healthcare Details, Company Type, Circulating Biomarker for Liquid Biopsy Area Served and Its Competitors
Table 65. GE Healthcare Circulating Biomarker for Liquid Biopsy Product Offered
Table 66. GE Healthcare Main Business
Table 67. GE Healthcare Circulating Biomarker for Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. GE Healthcare Latest Developments
Table 69. Epigenomics AG Details, Company Type, Circulating Biomarker for Liquid Biopsy Area Served and Its Competitors
Table 70. Epigenomics AG Circulating Biomarker for Liquid Biopsy Product Offered
Table 71. Epigenomics AG Main Business
Table 72. Epigenomics AG Circulating Biomarker for Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Epigenomics AG Latest Developments
Table 74. Agilent Technologies Details, Company Type, Circulating Biomarker for Liquid Biopsy Area Served and Its Competitors
Table 75. Agilent Technologies Circulating Biomarker for Liquid Biopsy Product Offered
Table 76. Agilent Technologies Main Business
Table 77. Agilent Technologies Circulating Biomarker for Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Agilent Technologies Latest Developments
Table 79. Biocept Details, Company Type, Circulating Biomarker for Liquid Biopsy Area Served and Its Competitors
Table 80. Biocept Circulating Biomarker for Liquid Biopsy Product Offered
Table 81. Biocept Main Business
Table 82. Biocept Circulating Biomarker for Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Biocept Latest Developments
Table 84. Affymetrix Details, Company Type, Circulating Biomarker for Liquid Biopsy Area Served and Its Competitors
Table 85. Affymetrix Circulating Biomarker for Liquid Biopsy Product Offered
Table 86. Affymetrix Main Business
Table 87. Affymetrix Circulating Biomarker for Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Affymetrix Latest Developments
Table 89. Fluxion Biosciences Details, Company Type, Circulating Biomarker for Liquid Biopsy Area Served and Its Competitors
Table 90. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Product Offered
Table 91. Fluxion Biosciences Main Business
Table 92. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Fluxion Biosciences Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Circulating Biomarker for Liquid Biopsy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Circulating Biomarker for Liquid Biopsy Market Size Market Share by Type in 2021
Figure 7. Circulating Biomarker for Liquid Biopsy in Early Cancer Screening
Figure 8. Global Circulating Biomarker for Liquid Biopsy Market: Early Cancer Screening (2017-2022) & ($ Millions)
Figure 9. Circulating Biomarker for Liquid Biopsy in Therapy Selection
Figure 10. Global Circulating Biomarker for Liquid Biopsy Market: Therapy Selection (2017-2022) & ($ Millions)
Figure 11. Circulating Biomarker for Liquid Biopsy in Treatment Monitoring
Figure 12. Global Circulating Biomarker for Liquid Biopsy Market: Treatment Monitoring (2017-2022) & ($ Millions)
Figure 13. Circulating Biomarker for Liquid Biopsy in Recurrence Monitoring Orthopedics
Figure 14. Global Circulating Biomarker for Liquid Biopsy Market: Recurrence Monitoring Orthopedics (2017-2022) & ($ Millions)
Figure 15. Global Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application in 2021
Figure 16. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Player in 2021
Figure 17. Global Circulating Biomarker for Liquid Biopsy Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Circulating Biomarker for Liquid Biopsy Market Size 2017-2022 ($ Millions)
Figure 19. APAC Circulating Biomarker for Liquid Biopsy Market Size 2017-2022 ($ Millions)
Figure 20. Europe Circulating Biomarker for Liquid Biopsy Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size 2017-2022 ($ Millions)
Figure 22. Americas Circulating Biomarker for Liquid Biopsy Value Market Share by Country in 2021
Figure 23. Americas Circulating Biomarker for Liquid Biopsy Consumption Market Share by Type in 2021
Figure 24. Americas Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application in 2021
Figure 25. United States Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Circulating Biomarker for Liquid Biopsy Market Size Market Share by Region in 2021
Figure 30. APAC Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application in 2021
Figure 31. China Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Circulating Biomarker for Liquid Biopsy Market Size Market Share by Country in 2021
Figure 38. Europe Circulating Biomarker for Liquid Biopsy Market Size Market Share by Type in 2021
Figure 39. Europe Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application in 2021
Figure 40. Germany Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application in 2021
Figure 48. Egypt Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Circulating Biomarker for Liquid Biopsy Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 54. APAC Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 55. Europe Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 57. United States Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 58. Canada Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 61. China Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 62. Japan Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 63. Korea Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 65. India Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 66. Australia Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 67. Germany Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 68. France Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 69. UK Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 70. Italy Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 71. Russia Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 72. Spain Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 75. Israel Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Circulating Biomarker for Liquid Biopsy Market Size 2023-2028 ($ Millions)